{
    "organizations": [],
    "uuid": "fe3b59fd12e6532d5ea3dbee9bdda77f344b5d22",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-gets-anda/brief-glenmark-pharmaceuticals-gets-anda-approval-from-u-s-fda-for-clobetasol-propionate-spray-0-05-pct-idUSFWN1R80ZW",
    "ord_in_thread": 0,
    "title": "BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval From U.S. FDA For Clobetasol Propionate Spray, 0.05 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* SAYS ‚ÄçCO GETS ANDA APPROVAL FROM U.S. FDA FOR CLOBETASOL PROPIONATE SPRAY, 0.05 PERCENT\n* SAYS PRODUCT WILL BE MANUFACTURED AT BADDI PLANT IN INDIA Source text - bit.ly/2GbC7j2 Further company coverage:\n ",
    "published": "2018-03-27T11:22:00.000+03:00",
    "crawled": "2018-03-27T11:59:28.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "glenmark",
        "pharmaceutical",
        "ltd",
        "say",
        "get",
        "anda",
        "approval",
        "fda",
        "clobetasol",
        "propionate",
        "spray",
        "percent",
        "say",
        "product",
        "manufactured",
        "baddi",
        "plant",
        "india",
        "source",
        "text",
        "company",
        "coverage"
    ]
}